Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 13, 2019
Amneal Pharmaceuticals is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level.
read more
Wednesday, August 19, 2015
Amneal Pharmaceuticals has announced the launch of aripiprazole oral solution in 1 mg/mL strength.
read more
Thursday, February 01, 2018
Amneal Pharmaceuticals has launched isotretinoin capsules, USP, an AB-rated generic for Accutane in 10 mg, 20 mg, 30 mg and 40 mg strengths.
read more
Amneal Pharmaceuticals announced Thursday Tasos Konidaris was appointed as senior vice president, chief financial officer, effective March 12.
read more
Wednesday, January 20, 2016
AMPAC Fine Chemicals LLC has announced the appointment ofAslam Malik, Ph.D., to the position of President and Chief Executive Officer (CEO) effective January 1, 2016.
read more
AMPAC Fine Chemicals announced Lee Gauthier has joined AFC's executive team as Vice President of Operations responsible for manufacturing across all AFC's sites.
read more
Tuesday, October 24, 2017
AMPAC Fine Chemicals announced Don Whiteaker has been promoted to Vice President, Supply Chain and Dr. Jeff Butler has been promoted to Executive Director, Project Management.
read more
AMPAC Fine Chemicals LLC (AFC) reports their "AMPAC Analytical" Business Unit has recently quadrupled their Analytical Services capacity to meet significantly growing customer demand for highly specialized testing. AMPAC Analytical has added 13,000 ...
read more
AMPAC Fine Chemicals (AFC) has announced that Joe Campbell has been promoted to the position of Vice President of Operations and Engineering, and Frank Mueller has been promoted to the position of Director, Lean Enterprise and Operational Excellence...
read more
Wednesday, January 03, 2024
Ampersand Biomedicines has acquired AbCheck s.r.o., a technology company specializing in antibody discovery for challenging targets and formerly a wholly-owned subsidiary of Affimed GmbH. Ampersand, a multi-product platform company focused on ...
read more
Ampersand Capital Partners and 1315 Capital, has completed the acquisition of Genoptix, Inc. from Novartis. The financial terms of the transaction are not being disclosed.
read more
Amphastar announced the FDA has approved its ANDA for Succinylcholine Chloride Injection USP, 200 mg/10 mL Multiple-Dose Vial.
read more
Wednesday, February 06, 2019
Amplicare announced the addition of two new benefits to its suite of solutions aimed at helping pharmacists improve patient care and health outcomes.
read more
Tuesday, September 10, 2019
AMRA has entered into an exclusive agreement with Micro, to guide and support pharmaceutical and research clients in Japan with clinical trials.
read more
Albany Molecular Research, Inc. announces expanded access to its accelerated solutions platform, spanning research & development to manufacturing for orphan and rare disease products.
read more